• AB Science completed settlement and delivery for a EUR 14.2 million private placement announced Aug. 10.
• Issued 23,278,692 new shares at EUR 0.61, each bundled with BSA-1 or BSA-2 warrants.
• Full exercise would add 36,590,166 shares, raising about EUR 36.6 million at EUR 1 per share.
• Total proceeds could reach about EUR 50.8 million if all warrants are exercised.
• Chairman-CEO Stéphane Ledermann participated for EUR 150,000.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB Science SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608170134OMX_____CNEWS_EN_GNW1001257849_en) on August 17, 2026, and is solely responsible for the information contained therein.